Oncolytics Biotech News

Aktie
WKN:  A2JMW5 ISIN:  CA6823108759 Branche:  Biotechnologie Land:  Kanada
0,9403 $
+0,0854 $
+9,99%
0,8037 € 01.04.26
Depot/Watchlist
Marktkapitalisierung *
62,33 Mio. €
Streubesitz
94,71%
KGV
-3,21
Index-Zuordnung
Nasdaq Composite Index

Oncolytics Biotech News

26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
24.06.25 - PR Newswire
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices PR Newswire
24.06.25 - PR Newswire
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices PR Newswire
20.06.25 - PR Newswire
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology PR Newswire
20.06.25 - PR Newswire
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology PR Newswire
18.06.25 - PR Newswire
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going PR Newswire
18.06.25 - PR Newswire
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going PR Newswire
12.06.25 - PR Newswire
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry PR Newswire
12.06.25 - PR Newswire
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry PR Newswire
12.06.25 - PR Newswire
After Major Oncology Conference, All Eyes Turn to Industry Innovation
After Major Oncology Conference, All Eyes Turn to Industry Innovation PR Newswire
12.06.25 - PR Newswire
After Major Oncology Conference, All Eyes Turn to Industry Innovation
After Major Oncology Conference, All Eyes Turn to Industry Innovation PR Newswire
11.06.25 - PR Newswire
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs PR Newswire
23.05.25 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
New Data and Deal Flow Signal a Turning Point for Precision-​Driven Cancer Biotechs PR Newswire
23.05.25 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
New Data and Deal Flow Signal a Turning Point for Precision-​Driven Cancer Biotechs PR Newswire
23.05.25 - PR Newswire
Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities
Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities PR Newswire
14.05.25 - PR Newswire
Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum
Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum PR Newswire
06.05.25 - PR Newswire
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights PR Newswire
01.05.25 - PR Newswire
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty PR Newswire
01.05.25 - PR Newswire
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty PR Newswire

Newssuche

Videos

newspaper
20.04.26 -0,69%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »